EVIO prepares for further diversification and evaluates new growth opportunities.

EVIO Inc. (OTCMKTS:EVIO)

HENDERSON, NV, USA, March 31, 2022 /EINPresswire.com/ -- EVIO, Inc. (OTC: EVIO) announced today that William H. Waldrop has been named as President and Chief Executive Officer.

Mr. Waldrop served as EVIO’s Chief Executive Officer for six years building a nationwide testing company. He took time away from the company to focus on his health in late 2020, also during this time he founded Tiderock Companies (TDRK) a real estate advisory services and development company in which he still serves as a Director and Chief Financial Officer.

Ms. Glauser has assumed the role of Chief Operating Officer, and will focus on Blockchain Technologies, leveraging EVIO’s analytical testing expertise along with identifying potentially new areas for EVIO to diversify. Mr. Waldrop, expressed his support for Ms. Glauser, “Lori has done a tremendous job managing the business during a very difficult time for the Company. She continued the efforts to prepare EVIO for future growth opportunities, identifying and executing strategic partnerships, while eliminating millions of dollars of debt from the balance sheet.”

Mr. Waldrop continued to comment, “I am returning to EVIO with a clearer perspective, open eyes, and an open mind. There is still a lot of work to do to complete the turn-around, at the same time we have an abundance of opportunity as we evaluate options to diversify our holdings and more importantly focus on increasing shareholder value.

Furthermore, the company has no plans to perform a reverse stock split in the foreseeable future. We feel the current PPS provides ample opportunity for shareholders to benefit from the work efforts that are underway. The only downside at this PPS, is that any debt conversion or share issuance for cash, appears to have dramatic impact on the number of outstanding shares while having marginal impact on the overall market value.”

About EVIO

EVIO, Inc. (“EVIO”) is a diversified holding company. Current operations include pharmaceutical, environmental, stability and analytical testing in the US and Canada. EVIO is currently evaluating opportunities to further diversify its holdings.

For more information, visit www.eviolabs.com

Safe Harbor Statement

Any statements in this press release that are not statements of historical fact may be considered forward-looking statements pertaining to anticipated or projected plans, performance, and developments, as well as other statements relating to future operations and results. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only, and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, the Company's ability to complete product testing and launch product commercially, the acceptance of product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in Company reports available at www.eviolabs.com.

William Waldrop
EVIO Inc.
+1 702-748-9944
info@evioinc.com
Visit us on social media:
Twitter